| Course | NRNP 6539 Advanced Primary Care of Adults |
|---|---|
| Week | Week 11 |
| Paper type | Peer replies discussion |
| Length | About 580 words, 4 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | Master of Science in Nursing (MSN) |
| Updated | October 2026 |
Free sample paper for NRNP 6539 Week 11
Week 11 Discussion: Peer Replies
When Credible Guidelines Disagree: Three Replies on Blood Pressure Thresholds, Guideline Quality, and Aspirin
Reply to Melissa
Melissa, you wrote: "When two guidelines disagree, the newest one should always govern." You are right that newer guidelines can incorporate evidence the older ones did not have, and that recency is a reasonable starting point. The evidence complicates the rule, though. The 2014 panel report from members of the Eighth Joint National Committee recommended starting treatment in adults 60 and older at a systolic pressure of 150 mm Hg, with a goal below 150/90 (James et al., 2014). Three years later, the ACC/AHA guideline defined hypertension at 130/80 and set a goal below 130/80 for most adults, drawing heavily on the SPRINT trial (Whelton et al., 2018). Both panels were credible and both reviewed overlapping evidence; they weighed benefit against harms such as falls, kidney injury, and syncope in older adults differently, and they used different methods for rating evidence. Newer does not automatically mean better for a given patient; it means a different reading of the evidence, which has to be matched to the person in front of us. In a chart I would document which guideline I followed, the target I chose, and why, for example: "Goal below 130/80 per 2017 ACC/AHA; patient tolerates without orthostasis." Would you apply the newer threshold to a frail 84-year-old with falls?
Reply to Aaron
Aaron, you wrote that for your hypothetical 79-year-old woman with diabetes and heart failure, "any major society guideline is equally trustworthy." I agree that society endorsement is a useful signal. What complicates it is that guidelines differ in how rigorously they were developed. The AGREE II instrument appraises guidelines across domains such as rigor of development, editorial independence, stakeholder involvement, and applicability, and it lets a clinician judge which recommendation earns more confidence for a specific decision (Brouwers et al., 2010). For her, a guideline that included older adults with multiple conditions in its evidence review, declared and managed its authors' conflicts of interest, and explained how it handled trade-offs between conditions would earn more confidence than one built on trials that excluded patients like her. In the chart, I would note the guideline used and one sentence on why it fits, for example that it addresses multimorbidity. Did either guideline you compared report how it handled conflicts of interest?
Reply to Natalie
Natalie, you wrote that "daily aspirin is still recommended for most adults over 50 to prevent heart attacks." You are right that aspirin was once widely recommended for primary prevention, and that many patients still take it on that basis. The evidence has changed. In 2022 the USPSTF concluded that for adults 40 to 59 with a 10-year cardiovascular risk of 10 percent or more, starting low-dose aspirin for primary prevention is an individual decision with a small net benefit, and it recommended against starting aspirin for primary prevention in adults 60 and older, because the risk of bleeding, including gastrointestinal and intracranial bleeding, offsets the benefit (US Preventive Services Task Force [USPSTF], 2022). That recommendation applies to people without known cardiovascular disease; patients with prior heart attack or stroke are a different question. In a chart I would document the patient's age, estimated risk, bleeding risk factors, and the shared decision, especially when stopping aspirin a patient has taken for years. How would you approach a 66-year-old who has taken aspirin daily for a decade and has never had cardiovascular disease?
References
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., Littlejohns, P., Makarski, J., & Zitzelsberger, L. (2010). AGREE II: Advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal, 182(18), E839-E842. https://doi.org/10.1503/cmaj.090449
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Jr., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Jr., Narva, A. S., & Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507-520. https://doi.org/10.1001/jama.2013.284427
US Preventive Services Task Force. (2022). Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA, 327(16), 1577-1584. https://doi.org/10.1001/jama.2022.4983
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., . . . Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13-e115. https://doi.org/10.1161/HYP.0000000000000065
What the NRNP 6539 Week 11 instructions ask for
The closing NRNP 6539 discussion often asks you to respond to classmates on how to handle conflicting clinical guidelines. Some sections require three replies instead of an initial post. Each reply should engage a specific claim, add evidence and move the discussion forward. Faculty grade what the reply adds more than whether it agrees. Cite guideline documents, trials or appraisal tools in APA 7. Examples such as blood pressure targets or aspirin for primary prevention work well because the guidance has changed. Keep each reply focused on one point. Respect for the classmate's view matters, and disagreement backed by evidence is welcome. In NRNP 6539 the replies are often graded individually, so each one has to stand on its own with a clear point and a citation.
How this NRNP 6539 Week 11 example is built
Quotation starts every reply, the specific claim it answers, and three moves follow: what the peer got right, where the evidence complicates it, and what the author would document in a chart. The first answers a peer who argued that the newest guideline always governs, using the ACC/AHA 2017 blood pressure guideline and the JNC 8 panel report to show two credible bodies reading overlapping evidence toward different thresholds. The second takes up a hypothetical older adult from a peer's post and applies the AGREE II instrument to explain why one guideline's development process earns more confidence for that decision. The third addresses aspirin for primary prevention, citing the USPSTF's revised recommendation and the bleeding concerns that narrowed it. Each reply finishes with a direct question for the classmate and carries two current references.
NRNP 6539 Week 11 rubric: what earns full marks
Closing replies are graded less on agreement than on what they add. Restating the peer's point in warmer words collects participation credit at best, while one that brings a new source, complicates a claim, or asks a question the peer must answer earns the substantive credit most rubrics reserve for this week. The AGREE II reply tends to score well because it shows guideline appraisal as a skill rather than guideline citation as a habit. Currency matters more than usual when the topic is guideline change, so a reply citing a superseded aspirin recommendation undoes its own argument. Tone is marked too. Disagreement framed as correction of a colleague reads differently from disagreement framed as a shared question, and the second is what these replies model throughout.
NRNP 6539 Week 11 help: mistakes that cost marks
Closing replies lose most of their credit when they restate the classmate's point in warmer words. Add a study, a counterexample or a tool. Another frequent problem is accepting a simple rule, such as newest wins, without testing it. Show a case where it fails. Writers also cite guidelines without saying who wrote them or how they rated evidence. Use AGREE II or the guideline's own grading. Avoid long replies that cover several topics thinly. Get the aspirin change right: the USPSTF narrowed its advice in 2022. Name the trials behind the blood pressure debate. End every reply on something the classmate can test. Writers also forget to say what they would actually do for a patient when the guidelines conflict, which is the practical point of the thread.
Get a NRNP 6539 Week 11 example written to your instructions
Send the final discussion question from your Week 11 prompt, the rubric, and the peer posts you need to answer, stripped of classmates' names. Replies are written to those posts, each opening on a quoted claim and adding a current source. A first custom sample is free and returns in 24-48 hours, sized to your word minimums.
More NRNP 6539 papers and MSN samples
- NRNP 6539 Week 1: Adult Primary Care Post
- NRNP 6539 Week 2: Hyperlipidemia SOAP Note
- NRNP 6539 Week 3: Hyperthyroidism Note
- NRNP 6539 Week 4: COPD Exacerbation SOAP Note
- NRNP 6539 Week 5: CKD and Gout SOAP Note
- NRNP 6539 Week 6: Knee Imaging Discussion
- NRNP 6539 Week 7: Reflux Dyspepsia Note
- NRNP 6539 Week 8: Depression Screening Note
- NRNP 6539 Week 9: Health Maintenance Plan
- NRNP 6539 Week 10: Obesity Care Plan
- NRNP 6540 Week 11: Transition Visit Note
- NRNP 6537 Week 11: Judgment Reflection
- NRNP 6547 Week 11: Reflection
- NRNP 6531 Week 11: Multi-Problem SOAP Note
NRNP 6539 Week 11 questions, answered
Why do blood pressure guidelines disagree?
Largely because panels weigh the same trials differently, deciding how much benefit justifies more treatment, more visits, and more side effects, and which populations the trials represent. The ACC/AHA guideline and the JNC 8 panel report drew their lines in different places for that reason. The example presents both as defensible readings, which is the position graders tend to credit in a discussion about guideline conflict.
What is AGREE II?
The Appraisal of Guidelines for Research and Evaluation instrument, a widely used tool for judging the quality of a clinical practice guideline across domains such as scope, stakeholder involvement, rigor of development, clarity, applicability, and editorial independence. It rates how a guideline was made, not whether its conclusions are convenient. The example applies the domains relevant to one decision rather than scoring every item.
What if my last week has no discussion?
Walden revises this course, and some sections close with a final note or a reflective post instead of a thread. Where a discussion does close the term, rubrics usually expect replies of substance and a visible response to feedback. If your final week asks for something else, the desk writes to that, keeping the habit this example models of sourcing every claim.
Where can I find a free NRNP 6539 Week 11 sample paper?
The three replies to Melissa, Aaron and Natalie are laid out here; the margin notes show how each one adds evidence instead of agreement.
What problem do the NRNP 6539 Week 11 replies take up?
What a nurse practitioner should do when credible guidelines disagree, answered differently for each of three classmates.